17 research outputs found
Implantation of atrial flow regulator devices in patients with congenital heart disease and children with severe pulmonary hypertension or cardiomyopathy - an international multicenter case series
Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment
International audienc
Xérostomie induite par anti-PD1/PDL1 : caractérisation clinique, immunohistochimique et proposition de prise en charge
301 Management of patients with advanced stage epithelial ovarian cancer: results of a national french survey on current practices in 2021
Xérostomie induite par anti-PD1/PDL1 : caractérisation clinique, immunohistochimique et proposition de prise en charge
Blalock-Taussig shunt versus duct stenting for congenital heart diseases with ductal-dependent pulmonary circulation: Multicenter international study (BLADE)
SAPIEN valve infective endocarditis after transcatheter pulmonary valve replacement: A multicenter international observational cohort
662 An international survey of practice patterns in ovarian cancer: what we stand for in 2021
Application en France des recommandations européennes 2021 sur le cancer de l’endomètre [Application in France of the 2021 European recommendations on endometrial cancer]
The latest European recommendations of the European Societies of Gynecological Oncology (ESGO), Radiotherapy and Oncology (ESTRO) and Anatomopathology (ESP) concerning the management of patients with endometrial cancer were published in 2021. On behalf of the French Society of Gynecologic Oncology (SFOG) and the SFOG campus, we wish to summarize for the French-speaking readership the main measures with a more specific application for France. We also incorporate data from a Delphi survey conducted with a panel of French and French-speaking Swiss experts. The data presented in this article relate to histo-molecular characteristics, radiological data of endometrial cancer, and management of low-risk, intermediate-risk, intermediate-high-risk, and metastatic cancers. The aim of this review article is to show the application of the latest international recommendations to clinicians and pathologists for the implementation of these recommendations
